Featured Articles

Body-Swapping with a Mannequin

Body-Swapping with a Mannequin

Dec 05 2008 | comment(s)

If you need more proof of how easy the human brain is to fool, hop over to Scientific American's 60 second science and read about how a group of mad scientists used virtual reality goggle to get subjects to 'body-swap' with a mannequin.

I'm waiting for the Wii version.
Microsoft Appoints Dr. Qi Lu To Run Online Services Group

Microsoft Appoints Dr. Qi Lu To Run Online Services Group

Dec 04 2008 | comment(s)

REDMOND, Washington, December 4 /PRNewswire/ --

- Yahoo! veteran to oversee Internet offerings for consumers, advertisers and publishers.

Microsoft Corp. today announced that Dr. Qi Lu will join the company as president of the Online Services Group. Dr. Lu will lead Microsoft's efforts in search and online advertising and all the company's online information and communications services. Dr. Lu will report to Microsoft Chief Executive Officer Steve Ballmer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

Triple Canopy Sponsors Iraq Energy Expo And Conference

Triple Canopy Sponsors Iraq Energy Expo And Conference

Dec 04 2008 | comment(s)

HERNDON, Virginia, December 4 /PRNewswire/ --

- Leading Integrated Security Company Safeguards Oil and Gas Sector

Triple Canopy, Inc., a leading provider of integrated security solutions to organizations worldwide, will sponsor the Iraq Energy Expo scheduled to take place Dec. 5 to 7 at the Baghdad International Airport Convention Center.

Licensed by the government of Iraq, Triple Canopy has supported the reconstruction process since 2004 and is proud to be a sponsor of the Iraq Energy Expo, said Lee Van Arsdale, CEO of Triple Canopy. From executive and fixed-site protection to full service life support and training, Triple Canopy is meeting the needs of the energy sector.

MTS Introduces New TestSuite Software Platform

MTS Introduces New TestSuite Software Platform

Dec 04 2008 | comment(s)

EDEN PRAIRIE, Minnesota, December 4 /PRNewswire/ --

- Modular software suite scales to meet testing professionals' needs.

MTS Systems Corporation (Nasdaq: MTSC) today announced the availability of the latest innovation in testing software: MTS TestSuite(TM) Software. This modular suite of software solutions provides new tools for creating and running tests, generating reports and analyzing test data for material and component tests. It gives testing professionals the control they need to test to their specific requirements.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020430/MTSCLOGO )

Gene Therapy Cures Sickle Cell In Mice

Gene Therapy Cures Sickle Cell In Mice

Dec 04 2008 | comment(s)

As our knowledge of biology has increased exponentially, so has our potential to find new treatments and technologies to battle ailments previously incurable. However, many of these expansions of knowledge have faced stalling challenges and hurdles, halting practical applications. Gene therapy has been one of these dreams, touted as having endless potential, yet viable medical treatments were always yet to be developed. This is all about to change, as new laboratory research has seen unprecedented developments in gene therapy.
Is Driving And Talking Too Much?

Is Driving And Talking Too Much?

Dec 04 2008 | comment(s)

So if you are still unsure whether it's unsafe to drive while talking on a cell phone, come out of your cave.  Multiple recent studies have supported that cell phone use endangers drivers. It seems that every week or so there's a new study out linking increased reaction times to the distraction caused by having a cell phone conversation, often comparing it to other types of impairments such as drinking or listening to the radio. As the research becomes more and more conclusive, scientists have attempted to find comparisons that are relevant than just a number in milliseconds.
Two-Year Follow-Up Data Demonstrates Preservation Of Adequate Mitral Valve Area In Patients Treated With The MitraClip(R) System

Two-Year Follow-Up Data Demonstrates Preservation Of Adequate Mitral Valve Area In Patients Treated With The MitraClip(R) System

Dec 04 2008 | comment(s)

MENLO PARK, California, December 4 /PRNewswire/ --

- EVEREST Data Shows that the MitraClip(R) Therapy does not produce Clinically Significant Mitral Stenosis

Long-term data published in EuroIntervention showed that the expected decrease in Mitral Vale Area (MVA) after repair with the MitraClip(R) system to correct mitral regurgitation (MR) is not associated with clinically significant mitral stenosis. Additionally, with two years of follow-up, none of the patients treated with the MitraClip(R) system required surgery for mitral stenosis. At 12 months no important differences were reported between the use of one or two MitraClip(R) devices or based on the etiology of MR.

10th Annual Platts Global Energy Awards Salute Winners In Three New Performance Categories

10th Annual Platts Global Energy Awards Salute Winners In Three New Performance Categories

Dec 04 2008 | comment(s)

NEW YORK, December 4 /PRNewswire/ --

- Sustainability Serves as Platform for Awards Ceremony and 2nd Platts Lecture

As part of the prestigious Global Energy Awards presented here last night, Platts announced winners in three newly-created or updated performance award categories: Peabody Energy for Strategic Energy Investment of the Year, Orion Energy Systems for Sustainable Technology Innovation of the Year and Wal-Mart Stores for Sustainable Energy Initiative of the Year.

Our finalists and winners for 2008 are contributors at the very highest level to the energy industry, said Platts President Victoria Chu Pao.

Qtrax Announces Global Agreement With SONY BMG MUSIC ENTERTAINMENT

Qtrax Announces Global Agreement With SONY BMG MUSIC ENTERTAINMENT

Dec 04 2008 | comment(s)

NEW YORK, December 4 /PRNewswire/ --

Qtrax, the ad-supported digital music service, today announced a global agreement with SONY BMG MUSIC ENTERTAINMENT that will make SONY BMG's premier digital music catalogue available to music fans worldwide on the Qtrax platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081111/CLTU129LOGO )

We are always exploring new and exciting ways of bringing our music to fans in the digital space and are very happy to support Qtrax and their innovative ad-supported business model, commented Thomas Hesse, SONY BMG's President of Global Digital Business and U.S. Sales.

Global Crossing Announces Conference Call For GCUK's Third Quarter Financial Results

Global Crossing Announces Conference Call For GCUK's Third Quarter Financial Results

Dec 04 2008 | comment(s)

LONDON, December 4 /PRNewswire/ --

Global Crossing (Nasdaq: GLBC) will conduct a conference call on Thursday, December 11, 2008 at 9:00 a.m. EST/2:00 p.m. GMT. John Kritzmacher, CFO and Anthony Christie, managing director for Global Crossing UK (GCUK) and Europe, will discuss GCUK's financial results for the third quarter of 2008.

The call may be accessed by dialing +1-212-231-2926 or +44-(0)-20-3300-0097. Callers are advised to dial in 15 minutes prior to the start time. The call will also be Webcast at http://investors.globalcrossing.com/results.cfm.

Wagamama Selects MICROS To Expand Its Dining Operations

Wagamama Selects MICROS To Expand Its Dining Operations

Dec 04 2008 | comment(s)

LONDON, December 4 /PRNewswire/ --

MICROS-Fidelio UK Ltd, a wholly-owned subsidiary of MICROS Systems, Inc. (Nasdaq: MCRS), is pleased to announce that wagamama, a chain of award-winning pan-asian inspired noodle restaurants, is implementing an extensive range of MICROS products. The product suite wagamama is deploying includes MICROS Restaurant Enterprise Series (RES), mymicros.net, Mobile MICROS, and the newest addition to the MICROS portfolio, myCentral -- a web-based application that empowers enterprises to extend their business beyond the four walls of the restaurant by allowing customers to place orders via the Internet or a centralized call center.

Myleene Klass Surprises With A Performance Of Volume Body For Pantene Pro-V

Myleene Klass Surprises With A Performance Of Volume Body For Pantene Pro-V

Dec 04 2008 | comment(s)

LONDON, December 4 /PRNewswire/ --

- With Photo

After a prolific 2008, hosting her Classic FM weekend breakfast show, presenting Last Choir Standing on BBC 1 and reporting for CNN, Myleene Klass announces a brand new role - as Pantene Pro V's global ambassador.

2009 promises to be even more exciting. As well as adding the prestigious position of Ten Years Younger host to her impressive CV, Myleene stars in Pantene's stunning new advertising campaign for the launch of its Volume and Body range.

0.000789% rate of allergic reaction to Gardasil saddens hypochondriacs

0.000789% rate of allergic reaction to Gardasil saddens hypochondriacs

Dec 04 2008 | comment(s)

The BMJ published a retrospective cohort study today showing only 3 out of 380,000 females ages 12-26 in Australia had 'probable' hypersensitivity to the cervical cancer vaccine Gardasil.

Unlike the U.S., where for some unfathomable reason some people still fight tooth and nail against vaccines, Australia has had a nationwide program to vaccinate females in that age group since April 2007.

There were 35 reports of suspected hypersensitivity, but only reactions from three of the 25 patients that agreed to skin-prick and injection (to confirm reactions) were likely tied to the vaccine.

The blurb on the BMJ site says:
European Commission Approval Of New Indication For Roche's Pegasys(R) (peginterferon Alfa-2a) Offers Hepatitis C Patients A Second Chance For A Cure

European Commission Approval Of New Indication For Roche's Pegasys(R) (peginterferon Alfa-2a) Offers Hepatitis C Patients A Second Chance For A Cure

Dec 04 2008 | comment(s)

BASEL, Switzerland, December 4 /PRNewswire/ --

- Pegasys is the First and Only Pegylated Interferon to be Approved for Treatment of up to 72 Weeks in Treatment-Experienced Patients

Roche announced today that the European Commission has approved Pegasys(R) (peginterferon alfa-2a (40 KD)) plus Copegus(R) (ribavirin) for the retreatment of hepatitis C patients who were not successfully treated with an initial course of interferon alpha (pegylated or non-pegylated), either alone or in combination with ribavirin.

Kiadis Pharma Announces Positive Clinical Results For ATIR(TM) In Mismatched Bone Marrow Transplantations

Kiadis Pharma Announces Positive Clinical Results For ATIR(TM) In Mismatched Bone Marrow Transplantations

Dec 04 2008 | comment(s)

AMSTERDAM, December 4 /PRNewswire/ --

- Kiadis Pharma Proceeds With Pivotal Trial ATIR(TM)

Biopharmaceutical company Kiadis Pharma announces today that it has successfully completed treatment of the last patient on its ATIR(TM) phase I/II clinical trial. ATIR(TM), a donor lymphocyte cell based product, is under development to prevent acute Graft versus Host Disease (GvHD) and allow early immune reconstitution following a mismatched bone marrow transplantation. Nineteen end stage blood cancer patients were treated with no cases of grade III/IV acute GvHD occurring within the first 100 days after ATIR(TM) infusion, showing the feasibility and tolerability of the addition of ATIR(TM) in combination with a mismatched transplant procedure.

Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones In Alzheimer's Disease Drug Development

Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones In Alzheimer's Disease Drug Development

Dec 04 2008 | comment(s)

LAUSANNE, Switzerland, December 4 /PRNewswire/ --

- AC Immune Selected as Technology Pioneer 2009 by the Word Economic Forum

- Phase II Clinical Trial for Small Molecule ACI-91 Approved

- First Patient Enrolled in Phase I Study of Anti-Abeta Antibody - Milestone Payment Received From Collaborator Genentech

AC Immune SA, a leader in Alzheimer’s disease drug development, announced today that the World Economic Forum has elected AC Immune as Technology Pioneer 2009 for its accomplishments as an innovation leader and for its breakthrough technologies that can have a deep impact on business and society.

Sky Player TV Uses Microsoft Silverlight And PlayReady Technology

Sky Player TV Uses Microsoft Silverlight And PlayReady Technology

Dec 04 2008 | comment(s)

LONDON and REDMOND, Washington, December 4 /PRNewswire/ --

- Silverlight and PlayReady enable BSkyB to deliver an expanded range of live content to Windows-based PC and Mac users.

Microsoft Corp. and BSkyB announce that Microsoft Silverlight and PlayReady technologies are enabling Sky Player TV, Sky's online TV service. Launched today, the service offers access to a range of leading pay TV entertainment as part of an online-only subscription. The new version of Sky Player TV, which in addition continues to be offered on a bonus basis to Sky's DTH (direct-to-home) customers, now delivers live linear channels and video-on-demand content to Windows-based PCs and, for the first time, includes live channel support for Macs.

MS Society Calls For Law Change On Unproven Stem Cell Trials

MS Society Calls For Law Change On Unproven Stem Cell Trials

Dec 04 2008 | comment(s)

LONDON, December 4 /PRNewswire/ -- Following yesterday's published guidelines on unproven stem cell treatments by the International Society for Stem Cell Research (ISSCR), the MS Society is calling on the Government to change the law on advertising medicines.

The MS Society supports the advice from the ISSCR that patients and their families should approach stem cell therapy with caution.

The Society has this week warned people with MS of a 'stem cell trial' being marketed from the Seychelles and Dubai, due to a lack of current evidence to support a stem cell treatment for MS.

Atmel Announces Grand Opening Of New Chinese Design Center And Regional Sales Operations In Shanghai

Atmel Announces Grand Opening Of New Chinese Design Center And Regional Sales Operations In Shanghai

Dec 04 2008 | comment(s)

SHANGHAI, China, December 4 /PRNewswire/ --

- Sales and design center dedicated to servicing mainland China

TapRoot Announces WalkingHotSpot Distribution Deal With Handango

TapRoot Announces WalkingHotSpot Distribution Deal With Handango

Dec 04 2008 | comment(s)

RESEARCH TRIANGLE PARK, North Carolina, December 4 /PRNewswire/ --

TapRoot Systems, Inc., a leading developer of software solutions for the smartphone market announced a distribution agreement with Handango Inc., the leading retailer of smartphone applications. The agreement provides Handango a worldwide license to distribute TapRoot's award winning WalkingHotSpot throughout Handango's numerous distribution channels.

WalkingHotSpot transforms Microsoft Windows Mobile and Symbian S60 3G/Wi-Fi smartphones into an anytime, anywhere, Wi-Fi hotspot wherever there is network coverage. Users can securely retrieve e-mails and browse the Internet while connecting multiple laptops or other Wi-Fi enabled devices simultaneously.